Winton Group LTD Fulcrum Therapeutics, Inc. Transaction History
Winton Group LTD
- $1.35 Billion
- Q4 2024
A detailed history of Winton Group LTD transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Winton Group LTD holds 12,997 shares of FULC stock, worth $48,218. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,997
Previous 44,201
70.6%
Holding current value
$48,218
Previous $157,000
61.15%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding FULC
# of Institutions
142Shares Held
48.8MCall Options Held
6.8MPut Options Held
1.73M-
Ra Capital Management, L.P. Boston, MA10.2MShares$37.9 Million0.51% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$19.5 Million2.43% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$17.8 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$17.7 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.25MShares$12.1 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $193M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...